FDA breast implants workshop
This article was originally published in The Gray Sheet
Executive SummaryMeeting to "provide a forum for the FDA to present draft guidance concerning testing requirements for alternative breast prostheses" is scheduled for Oct. 21 in Washington, D.C., FDA says. The meeting will also include "discussion and information exchange" by FDA and invited scientific experts. Participation from the public "will be limited to written questions" facilitated by a moderator, the agency notes. To register, call 301/608-3542
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.